You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complement C3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

C3G, IC-MPGN, C3 Glomerulopathy Trial (Pegcetacoplan)

Not yet recruiting
  • C3G
  • +11 more
  • (no location specified)
Apr 13, 2023

C3 Glomerulopathy (C3G) Trial (Iptacopan)

Available
  • C3 Glomerulopathy (C3G)
  • (no location specified)
Jan 24, 2023

Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis, Healthy Trial in Ranica (C3NEF assay)

Not yet recruiting
  • Hemolytic-Uremic Syndrome
  • +2 more
  • C3NEF assay
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Aug 9, 2023

Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy, IgA Nephropathy Trial in Korea, Republic of, New Zealand, Thailand

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • +2 more
  • Camperdown, New South Wales, Australia
  • +19 more
Sep 13, 2022

C3G, IC-MPGN, C3 Glomerulopathy Trial in Worldwide (Pegcetacoplan, Placebo)

Recruiting
  • C3G
  • +11 more
  • Birmingham, Alabama
  • +27 more
Aug 4, 2022

C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality Trial in Sweden (Aliskiren, Enalapril)

Recruiting
  • C3 Glomerulopathy
  • +4 more
  • Gothenburg, Sweden
  • +3 more
Jan 4, 2022

Geographic Atrophy, Macular Degeneration Trial in Dallas (Avacincaptad pegol 2 mg intravitreal injection)

Not yet recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Avacincaptad pegol 2 mg intravitreal injection
  • Dallas, Texas
    Retina Foundation of the Southwest
Sep 7, 2022

C3G, IC-MPGN, Renal Transplant Trial in Worldwide (Pegcetacoplan)

Recruiting
  • C3G
  • +11 more
  • Los Angeles, California
  • +21 more
Apr 5, 2022

Ankylosing Spondylitis, Spondyloarthritis Trial (Complement C3d test (blood sample))

Completed
  • Ankylosing Spondylitis
  • Spondyloarthritis
  • Complement C3d test (blood sample)
  • (no location specified)
Oct 1, 2020

Gingivitis Trial in Cambridge (AMY-101, Water for injection)

Completed
  • Gingivitis
  • Cambridge, Massachusetts
    Forsyth Institute
Feb 19, 2021

Complement C5a Receptors in Hidradenitis Suppurativa

Recruiting
  • Hidradenitis Suppurativa
    • Redwood City, California
      Stanford University
    Jun 27, 2022

    C3G Trial in Worldwide (Placebo, iptacopan)

    Recruiting
    • C3G
    • Aurora, Colorado
    • +60 more
    Nov 23, 2022

    C3 Dominant Glomerulonephritis Among Egyptian Population

    Recruiting
    • C3 Nephropathy
      • Sohag, Egypt
        Sohag university , faculty of medicine
      Nov 10, 2023

      Covid19, Thrombotic Microangiopathies, Acute Kidney Injury Trial in Boston (Ravulizumab)

      Active, not recruiting
      • Covid19
      • +2 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Dec 31, 2022

      Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19) Trial (AMY-101, WFI 5% glucose)

      Not yet recruiting
      • Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)
      • (no location specified)
      Feb 19, 2021

      Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Baltimore, Maryland
      • +4 more
      Feb 1, 2023

      C3 Glomerulopathy Trial (NM8074)

      Not yet recruiting
      • C3 Glomerulopathy
      • (no location specified)
      Jan 12, 2023

      Periodontal Diseases Trial in Chennai (Non surgical periodontal therapy)

      Not yet recruiting
      • Periodontal Diseases
      • Non surgical periodontal therapy
      • Chennai, Tamilnadu, India
      • +1 more
      Apr 26, 2023

      Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))

      Not yet recruiting
      • Generalized Myasthenia Gravis
      • zilucoplan (RA101495)
      • (no location specified)
      Aug 22, 2022

      Warts Trial in Zagazig (Candida antigen)

      Completed
      • Warts
      • Candida antigen
      • Zagazig, Sharqia, Egypt
        Zagazig University Faculty of Medicine
      May 24, 2020

      Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))

      Not yet recruiting
      • Pancreatic Cancer Metastatic
      • C3 (Metformin, Simvastatin, and Digoxin)
      • (no location specified)
      Sep 1, 2023

      Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

      Not yet recruiting
      • Neuromyelitis Optica Spectrum Disorder
      • +2 more
        • (no location specified)
        Jul 21, 2023

        C3 Glomerulonephritis, Dense Deposit Disease, C3 Glomerulopathy Trial in Melbourne, Antwerpen, Leiden (Danicopan)

        Completed
        Has Results
        • C3 Glomerulonephritis
        • +4 more
        • Melbourne, Australia
        • +2 more
        Oct 7, 2021

        Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

        Not yet recruiting
        • Advanced Pancreatic Adenocarcinoma
        • +2 more
        • Boston, Massachusetts
        • +1 more
        Aug 23, 2023

        Stargardt Disease 1 Trial in Worldwide (Zimura, Sham)

        Recruiting
        • Stargardt Disease 1
        • Phoenix, Arizona
        • +41 more
        Sep 7, 2022